HT
Insider
Helen Torley
PRESIDENT AND CEOHelen Torley (PRESIDENT AND CEO) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Halozyme Therapeutics, Inc. (HALO). The largest single filing was $6.4M of HALO (59,900 sh across 6 lots, as filed), executed Sep 9.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$39.1M
shares × price, as filed
Last traded
Sep 11
Filed Sep 11
Median ADV $214.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $54.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
11 filings
Sector per market data · by filing · past 12 months
Most traded names
HALORecent filings
HALOSALE
Halozyme Therapeutics, Inc.
View filing →
$1.7M30,000 sh across 3 lots
Exec Sep 24 2024
Filed Sep 26 2024 · 5:30 PM ET HALOSALE Halozyme Therapeutics, Inc. View filing → $1.8M
30,000 sh across 3 lots
Exec Sep 10 2024
Filed Sep 12 2024 · 5:30 PM ET